TORONTO, ON – August 26, 2021 – Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced the appointment of Mohammad Bataineh as the Company’s new President.
- Brings over 25 years of experience working in primary care, healthcare M&A, integrations, legal and operations;
- Will be responsible for management and execution of all internal functions including coordination with clinical, financial, and technology teams;
- Co-Founder Kash Qureshi will shift focus to Corporate Affairs, including Corporate Development, and will retain executive leadership while overseeing the Technology and Data Analytics teams. Mr. Qureshi remains an Executive Member of the Board of Directors;
- Executive leadership team continues to build in experience, leadership, and knowledge, with strong experience executing a national value based primary care model.
“This is a strong and strategic move for the Company as we execute on our pipeline and continue our plan of US expansion of M&A and VBC conversion,” said Prad Sekar, CEO of Skylight Health. “Over the last 5 months, Mohammad has actively had a key hand in executing against our largest acquisition of Rocky Mountain, as well as other acquisitions including ACO partners. He is working to flatten and strengthen our operational infrastructure and brings a level of management that has resonated strongly with our operational teams. His promotion to President represents a major step forward for the Company, and both myself and my co-founder, Kash Qureshi, are honored to welcome Mohammad into this role.”
“Being one of the co-founders and having served as President for the last 8 years, I welcome Mohammad into this role as I turn my attention to the data and analytics focus of our organization,” said Kash Qureshi, co-founder and Chief Corporate Officer at Skylight. “This is a strategic move given our focus on rapid growth across the US primary care market, and the growing level of capacity requirements across the Company.”
As the Company looks forward to rapid expansion, the need to consolidate Operations with all support functions, including Revenue Cycle, Compliance, Contracting, among others, remains a focus. As a result, the Company has removed the Chief Operations Role and will see Paul Kulas depart as part of this change. Operations, along with support functions, will now report directly into the President, and will work in close collaboration with Clinical, Finance and Technology teams. The Company is confident this structure will lead to a more streamlined execution across all national initiatives.
Mohammad Bataineh said, “I look forward to continue strong execution within my new role at Skylight Health, and now as part of the executive leadership team. The entrepreneurial nature of this Company, its team, and leadership style is what I believe will truly differentiate us from other players in this space. We are moving at such a rapid pace as we look to accelerate and scale our model through VBC conversion, the acquisition of more practices, and de novo sites. I will draw on my experience to drive this organization forward and bring increased value for all our stakeholders.”
Grant of Employee Options
The Company has granted Mohammad Bataineh a total of 156,000 options as part of his new role. In addition, the Company has granted a total of 216,000 options to other members of the organization as part of its quarterly option grant for new and current employees of the organization. All options granted were priced at the close of market on August 25, 2021, and will be vested in accordance with the employee option grant program.
